Amneal Pharmaceuticals, Inc. Business Finance Contracts & Agreements

30 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Capital Stock of Amneal Pharmaceuticals, Inc.
Stock Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2024
Term Sheet for Reorganization of Amneal Pharmaceuticals, Inc. and Affiliates
Term Sheets
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2023
Amendment No. 1 to Revolving Credit and Term Loan Agreement among Rondo Holdings, LLC, Rondo Intermediate Holdings, LLC, Subsidiary Loan Parties, Lenders, and Truist Bank
Loan Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Amendment No. 1 to Term Loan Credit Agreement among Amneal Pharmaceuticals LLC, Guarantors, and JPMorgan Chase Bank, N.A.
Credit Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Second Modification to Employment Agreement between Amneal Pharmaceuticals, Inc. and Andrew Boyer
Modification Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2023
Modification No. 1 to Employment Agreement between Amneal Pharmaceuticals, Inc. and Nikita Shah
Modification Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2023
Second Modification to Employment Agreement between Amneal Pharmaceuticals, Inc. and Anastasios G. Konidaris
Modification Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2023
Share Purchase Agreement among Amneal Pharmaceuticals Private Limited, Selling Shareholders, and Puniska Healthcare Private Limited (November 2, 2021)
Purchase Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2022
Asset Purchase Agreement among Saol Entities and Amneal Pharmaceuticals LLC dated December 30, 2021
Purchase Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Membership Interest Purchase Agreement between Kashiv BioSciences, LLC and Amneal Pharmaceuticals LLC (January 11, 2021)
Purchase Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Modification No. 1 to Employment Agreement between Amneal Pharmaceuticals, Inc. and Andrew Boyer
Modification Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2020
Description of Amneal Pharmaceuticals, Inc. Class A Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2020
Revolving Credit and Term Loan Agreement among Rondo Intermediate Holdings, LLC, Rondo Holdings, LLC, and Lenders, with Truist Bank as Administrative Agent (2020)
Credit Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Guaranty and Security Agreement among Rondo Intermediate Holdings, LLC, Subsidiaries, and Truist Bank (2020)
Guaranty Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Equity Purchase Agreement among Steve Shirley Business Trust, Jerry Shirley Business Trust, Jerry Brian Shirley Business Trust, Darren Thomas Shirley Business Trust, Troy Mizell,...
Purchase Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2019
Amendment No. 1 to Second Amended and Restated Stockholders Agreement by and among Amneal Pharmaceuticals, Inc. and Amneal Group Representative
Shareholders Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2019
Acknowledgment and Agreement Regarding Pledge of LLC Units and Company Shares by Amneal Pharmaceuticals Parties to Morgan Stanley Private Bank
Pledge Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Letter Agreement Regarding Promissory Note and Collateral Pledge among Amneal Pharmaceuticals, Credit Suisse, and Borrower
Pledge Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2019
Second Supplemental Indenture to 2.00% Convertible Senior Notes Due 2022 – Impax Laboratories, Inc., Amneal Pharmaceuticals, Inc., and Wilmington Trust, N.A.
Indenture Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
First Supplemental Indenture to 2.00% Convertible Senior Notes Due 2022 between Impax Laboratories, Inc. and Wilmington Trust, N.A.
Indenture Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Indenture Agreement for 2.00% Convertible Senior Notes due 2022 between Impax Laboratories, Inc. and Wilmington Trust, National Association
Indenture Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Letter Agreement Amending Share Purchase and Related Agreements Among Amneal Holdings, Atlas Holdings, and TPG Improv Holdings (November 21, 2017)
Purchase Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Second Supplemental Indenture to 2.00% Convertible Senior Notes Due 2022 – Impax Laboratories, Inc., Amneal Pharmaceuticals, Inc., and Wilmington Trust, N.A.
Indenture Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Purchase and Sale Agreement among Amneal Pharmaceuticals LLC, Gemini Laboratories, LLC, and Sellers (May 7, 2018)
Purchase Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Warrant Confirmation Agreement between Impax Laboratories, Inc. and Royal Bank of Canada (June 26, 2015)
Warrant Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Warrant Confirmation Agreement between Impax Laboratories, Inc. and RBC Capital Markets, LLC (June 25, 2015)
Warrant Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Second Amended and Restated Stockholders Agreement among Amneal Group and Atlas Holdings, Inc. dated December 16, 2017
Shareholders Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
First Supplemental Indenture to 2.00% Convertible Senior Notes Due 2022 between Impax Laboratories, Inc. and Wilmington Trust, N.A.
Indenture Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Indenture Agreement for 2.00% Convertible Senior Notes due 2022 between Impax Laboratories, Inc. and Wilmington Trust, National Association
Indenture Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Letter Agreement Amending Transaction Documents and Granting Registration and Observer Rights among Amneal Holdings, LLC, Atlas Holdings, Inc., and TPG Improv Holdings, L.P.
Modification Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018